Cargando…

SNPs Array Karyotyping in Non-Hodgkin Lymphoma

The traditional methods for detection of chromosomal aberrations, which included cytogenetic or gene candidate solutions, suffered from low sensitivity or the need for previous knowledge of the target regions of the genome. With the advent of single nucleotide polymorphism (SNP) arrays, genome scree...

Descripción completa

Detalles Bibliográficos
Autores principales:	Etebari, Maryam, Navari, Mohsen, Piccaluga, Pier Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996401/ https://www.ncbi.nlm.nih.gov/pubmed/27600240 http://dx.doi.org/10.3390/microarrays4040551

Ejemplares similares

Pathobiologic Roles of Epstein–Barr Virus-Encoded MicroRNAs in Human Lymphomas
por: Navari, Mohsen, et al.
Publicado: (2018)

The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma
por: Navari, Mohsen, et al.
Publicado: (2015)

Transcriptional Analysis of Lennert Lymphoma Reveals a Unique Profile and Identifies Novel Therapeutic Targets
por: Etebari, Maryam, et al.
Publicado: (2019)

Single-Step IGHV Next-Generation Sequencing Detects Clonality and Somatic Hypermutation in Lymphoid Malignancies: A Phase III Diagnostic Accuracy Study
por: Gazzola, Anna, et al.
Publicado: (2023)

SNPs Array Karyotyping Reveals a Novel Recurrent 20p13 Amplification in Primary Myelofibrosis
por: Visani, Giuseppe, et al.
Publicado: (2011)

Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis
por: Visani, Giuseppe, et al.
Publicado: (2023)

Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
por: Bagaloni, Irene, et al.
Publicado: (2021)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
por: De Falco, Giulia, et al.
Publicado: (2015)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

COVID-19 Vaccine: Between Myth and Truth
por: Piccaluga, Pier Paolo, et al.
Publicado: (2022)

Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda
por: Tumwine, Lynnette K, et al.
Publicado: (2009)

Hodgkin Reed–Sternberg-Like Cells in Non-Hodgkin Lymphoma
por: Parente, Paola, et al.
Publicado: (2020)

Cross-Immunization Against Respiratory Coronaviruses May Protect Children From SARS-CoV2: More Than a Simple Hypothesis?
por: Piccaluga, Pier Paolo, et al.
Publicado: (2021)

A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas
por: Piccaluga, Pier Paolo, et al.
Publicado: (2023)

Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas
por: Piccaluga, Pier Paolo, et al.
Publicado: (2015)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

Surgery for Non-Hodgkin’s Lymphoma
por: Weledji, Elroy Patrick, et al.
Publicado: (2015)

Epidemiology of Non-Hodgkin’s Lymphoma
por: Thandra, Krishna C., et al.
Publicado: (2021)

MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients
por: Navarro, Alfons, et al.
Publicado: (2013)

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
por: Grover, Natalie S., et al.
Publicado: (2015)

Autonomic dysfunction in Hodgkin and non-Hodgkin lymphoma. A paraneoplastic syndrome?
por: Bilora, Franca, et al.
Publicado: (2010)

Bendamustine in the treatment of non-Hodgkin’s lymphomas
por: Hagemeister, Fredrick, et al.
Publicado: (2009)

Rituximab in the treatment of non-Hodgkin’s lymphoma
por: Hauptrock, Beate, et al.
Publicado: (2008)

Non-Coding RNAs in Hodgkin Lymphoma
por: Cordeiro, Anna, et al.
Publicado: (2017)

Drug Resistance in Non-Hodgkin Lymphomas
por: Klener, Pavel, et al.
Publicado: (2020)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2019)

Tyrosine kinases in nodal peripheral T-cell lymphomas
por: Piccaluga, Pier Paolo, et al.
Publicado: (2023)

Non-Hodgkin's lymphoma: A review
por: Singh, Rohit, et al.
Publicado: (2020)

Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas
por: Loni, L, et al.
Publicado: (2001)

Current Immunotherapy Approaches in Non-Hodgkin Lymphomas
por: Pytlik, Robert, et al.
Publicado: (2020)

Systematic review of perchloroethylene and non-Hodgkin's lymphoma
por: Goodman, Julie E., et al.
Publicado: (2022)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Molecular Profiling of Aggressive Lymphomas
por: Rossi, Maura, et al.
Publicado: (2012)

MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma
por: Ambrosio, Maria Raffaella, et al.
Publicado: (2017)

Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
por: Kiani, Hadis, et al.
Publicado: (2016)

Expanded use of rituximab in the management of non-Hodgkin lymphoma
por: Eichenauer, Dennis A, et al.
Publicado: (2009)

The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma
por: Aldoss, Ibrahim T, et al.
Publicado: (2009)

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas
por: Poggio, Teresa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p5g63hlph0t3t8ehmadllfu4ra